Industrifonden

Industrifonden, established in 1979, is a Swedish venture capital firm focused on early-stage investments in technology and life science companies with international potential. It invests in sectors such as internet and media, information technology, life sciences, and industrial growth, with a particular interest in deep tech, AI, and disruptive technologies. The firm typically invests between SEK 5 million to SEK 100 million per company, seeking ownership interests of between 15 to 50 percent. Industrifonden provides financing through equity capital and various types of loans and guarantees, often co-investing with other regional venture capital firms. It actively supports its portfolio companies, typically taking a board seat and working long-term with entrepreneurs. The firm exits its investments usually within five to ten years through sales to industry players or initial public offerings. Notable Industrifonden-backed companies include Qlik, Arcam, and CellaVision.

Per Anell

Senior Investment Director and Practice Lead Transformative Tech

Iliam Barkino

Principal

Tomas Bie

Investment Director

Karolina Bjurehed

Investment Director

Jonas Brambeck Ph.D

Senior Investment Director

Hadar Cars

Senior Investment Director

Tobias Elmquist

Senior Investment Director

Tobias Elmquist

Senior Investment Director

Anna Haupt

Investment Director

Jonathan Ilicki

Principal

Anna Ljungdahl

Senior Investment Director

Caroline Murray

CFO

Anders Slettengren

CEO

Patrik Sobocki Ph.D

Senior Investment Director and Practice Lead Deep Tech

Andreas Söneby

Venture Partner

Tore Tolke

Investment Manager Technology

Mala Valroy

Investment Manager

Caroline Wachtmeister

Principal

Peter Wolpert

CEO

Matti Zemack

Investment Director

Sara Frykstrand Ångström

Associate

Caroline Wadstein

Investor

Past deals in Sweden

Gårdsfisk

Series A in 2025
Gårdsfisk AB, founded in 2013 and based in Åhus, Sweden, specializes in innovative land-based fish farming. The company has developed a unique method that utilizes large tanks within a closed system, allowing for the cultivation of fish while minimizing environmental impact. This approach enables the recycling of nutrient-rich wastewater as fertilizer for agricultural fields, enhancing sustainability. By providing farmers with the technology to breed fish domestically, Gårdsfisk aims to address the environmental challenges associated with traditional fish farming practices, promoting a more sustainable aquaculture industry.

Open Payments

Venture Round in 2025
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.

Gesynta Pharma

Series B in 2025
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.

Apica

Venture Round in 2024
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

TrusTrace

Series B in 2024
TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.

Fast Travel Games

Venture Round in 2023
Fast Travel Games, established in 2016 and headquartered in Stockholm, Sweden, specializes in developing virtual reality games. Founded by industry veterans from studios like EA DICE, Rovio, and Avalanche, the company aims to create immersive gaming experiences that allow players to explore rich narratives and interact with others in innovative ways. Their focus is on building games that leverage the unique capabilities of VR technology to provide deep, engaging universes for players.

Pixelgen Technologies

Series A in 2023
Pixelgen Technologies is a company focused on advancing biomedical research and diagnostics through the development of innovative bio-analytical tools. Founded in 2020 and based in Sweden, the firm specializes in creating novel analytical methods and products that enhance the understanding of biological processes. These tools are designed to provide researchers and drug developers with valuable insights into biomedicine, ultimately aiming to improve health outcomes. By delivering advanced solutions for biomedical analysis, Pixelgen Technologies plays a crucial role in supporting scientific discovery and development in the healthcare sector.

Apica

Venture Round in 2023
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

Virkesbörsen

Venture Round in 2023
Virkesbörsen is a Swedish company that operates a digital marketplace, facilitating the buying and selling of wood between suppliers and buyers.

Hopsworks

Series B in 2023
Hopsworks, founded in 2016 and based in Stockholm, Sweden, is a developer of a data platform that focuses on artificial intelligence and machine learning. The company offers Hops Enterprise Services, which utilizes deep learning, stream processing, and SQL capabilities. Hopsworks provides an on-premise data management and data science platform called Hopsworks Enterprise, which includes tools for planning, pricing, and calculating return on investment for data scientists. The platform is designed to support the development and management of feature, training, and inference pipelines at scale, catering to diverse data teams and sources. Hopsworks specializes in technologies such as TensorFlow, Flink, MySQL, and HDFS, enabling clients to implement AI solutions for complex business challenges with optimal performance and availability.

Open Payments

Venture Round in 2023
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.

Viking Analytics

Series A in 2023
Viking Analytics AB, based in Gothenburg, Sweden, develops advanced software solutions tailored for the manufacturing, chemical, and process industries. Established in 2012, the company specializes in its MultiViz analytics software, which assists industrial firms in preparing, analyzing, and organizing sensor data and condition monitoring information. This tool enables users to visualize data effectively, detect patterns, and monitor machine performance with greater reliability. Since 2018, Viking Analytics has focused on enhancing the capabilities of maintenance firms, original equipment manufacturers, and system integrators by identifying machines that require attention and providing insights into the reasons for their condition. By utilizing feedback from experts, the software continuously improves its performance, reducing false alarms and eliminating the need for companies to maintain their own artificial intelligence teams. Overall, Viking Analytics contributes to process optimization and minimizes unplanned maintenance interruptions through advanced anomaly detection and predictive analytics.

EnginZyme

Series B in 2022
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. The company specializes in biocatalysis and a cell-free synthetic biology platform to create sustainable alternatives to conventional materials such as plastics, nylons, and rubbers. EnginZyme's innovative approach focuses on biomanufacturing techniques that promote green chemistry across various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By utilizing patented cell-free technology, EnginZyme aims to replace traditional fossil-based manufacturing, thus facilitating the shift toward environmentally friendly production methods. The company has gained recognition for its contributions to sustainability, being named a Global Cleantech 100 company and recognized as a Technology Pioneer by the World Economic Forum. EnginZyme is supported by a diverse group of investors, reflecting its potential impact on addressing climate change and promoting sustainable practices in manufacturing.

Digip

Seed Round in 2022
Digip is a Swedish legal tech company specializing in software solutions for trademark registration and protection. Its platform offers an accessible and affordable approach to intellectual property management by digitizing traditional processes. With features designed for on-demand trademark registration and monitoring, Digip enables businesses and entrepreneurs to protect their brand names effectively in a user-friendly digital environment. By leveraging innovative technology and expertise, Digip aims to streamline the trademark protection process, reducing costs and enhancing the overall customer experience in managing intellectual property.

Occtoo

Seed Round in 2022
Occtoo AB is a software as a service company based in Vellinge, Sweden, that offers an Experience Data Platform aimed at enhancing digital experiences for retailers and brands. Founded in 2019, the platform enables marketers and content managers to easily orchestrate and personalize customer interactions by transforming enterprise data into actionable experience data. Occtoo provides no-code and low-code solutions that facilitate content personalization, dynamic product profiling, and customer insights, while also allowing for real-time data collection across various devices and channels. This technology streamlines the creation of applications and digital experiences, reducing the need for complex integrations. Notable clients include brands such as Cartier, Intersport, Fjällräven, and Filippa K, reflecting the platform's effectiveness in delivering tailored user experiences throughout the customer journey.

Airsonett

Venture Round in 2022
Airsonett is a medical device company focused on developing non-pharmaceutical treatments for allergic asthma and eczema. Its flagship product, the Air4, utilizes patented Temperature-controlled Laminar Airflow (TLA) technology to significantly reduce allergens and airborne irritants in a patient's breathing zone during rest and sleep. This innovative home medical device aims to provide relief for individuals suffering from allergic asthma and atopic eczema, primarily serving patients in Sweden and the UK. By offering a non-invasive solution, Airsonett addresses the need for effective prophylactic treatments without relying on traditional medication.

Elypta

Series A in 2022
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.

Nextory

Venture Round in 2022
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.

TrusTrace

Series A in 2021
TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.

Limina Investment Management Solution

Series A in 2021
Limina Investment Management Solution (IMS) is a Front-to-Middle Office Solution that let investment managers focus on what matters: producing investment returns with minimal operational risk. The open platform help Asset Managers overcome fragmented workflows and increase confidence in data and oversight. Limina was founded by former investment managers that set out to create a solution to the challenges they faced. The solution now offered by Limina is engineered in Sweden and delivered by industry experts globally.

Hopsworks

Series A in 2021
Hopsworks, founded in 2016 and based in Stockholm, Sweden, is a developer of a data platform that focuses on artificial intelligence and machine learning. The company offers Hops Enterprise Services, which utilizes deep learning, stream processing, and SQL capabilities. Hopsworks provides an on-premise data management and data science platform called Hopsworks Enterprise, which includes tools for planning, pricing, and calculating return on investment for data scientists. The platform is designed to support the development and management of feature, training, and inference pipelines at scale, catering to diverse data teams and sources. Hopsworks specializes in technologies such as TensorFlow, Flink, MySQL, and HDFS, enabling clients to implement AI solutions for complex business challenges with optimal performance and availability.

Fast Travel Games

Series B in 2021
Fast Travel Games, established in 2016 and headquartered in Stockholm, Sweden, specializes in developing virtual reality games. Founded by industry veterans from studios like EA DICE, Rovio, and Avalanche, the company aims to create immersive gaming experiences that allow players to explore rich narratives and interact with others in innovative ways. Their focus is on building games that leverage the unique capabilities of VR technology to provide deep, engaging universes for players.

Digip

Seed Round in 2021
Digip is a Swedish legal tech company specializing in software solutions for trademark registration and protection. Its platform offers an accessible and affordable approach to intellectual property management by digitizing traditional processes. With features designed for on-demand trademark registration and monitoring, Digip enables businesses and entrepreneurs to protect their brand names effectively in a user-friendly digital environment. By leveraging innovative technology and expertise, Digip aims to streamline the trademark protection process, reducing costs and enhancing the overall customer experience in managing intellectual property.

NuvoAir Medical

Series A in 2021
NuvoAir Medical, established in 2015 and headquartered in Stockholm, Sweden, specializes in a value-based specialty care platform for managing chronic heart and lung conditions. The company's core offering is a proactive, continuous virtual care model that combines personalized care, advanced monitoring technology, and analytics, delivered by a multidisciplinary team of healthcare professionals. NuvoAir collaborates with health plans and risk-bearing entities, employing flexible, value-based payment arrangements to reduce healthcare costs and improve patient outcomes.

Exeri

Venture Round in 2021
Exeri AB, founded in 2009 and based in Luleå, Sweden, specializes in transforming traditional electric grids into Smart Grids through its innovative Smart Grid Surveillance (SGS) system. This comprehensive technology digitizes electric grid networks, enabling real-time monitoring and providing network owners with up-to-date information on their systems. Exeri's solution enhances the security of electricity networks by facilitating quick problem detection and reducing power outage durations. Utilizing IoT technology and AI-driven algorithms, the system offers precise error localization, predictive maintenance capabilities, and decision support tools. This not only improves the efficiency of electricity grids but also supports the integration of renewable energy sources and the charging of electric vehicles, contributing to a sustainable energy future.

EnginZyme

Series A in 2021
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. The company specializes in biocatalysis and a cell-free synthetic biology platform to create sustainable alternatives to conventional materials such as plastics, nylons, and rubbers. EnginZyme's innovative approach focuses on biomanufacturing techniques that promote green chemistry across various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By utilizing patented cell-free technology, EnginZyme aims to replace traditional fossil-based manufacturing, thus facilitating the shift toward environmentally friendly production methods. The company has gained recognition for its contributions to sustainability, being named a Global Cleantech 100 company and recognized as a Technology Pioneer by the World Economic Forum. EnginZyme is supported by a diverse group of investors, reflecting its potential impact on addressing climate change and promoting sustainable practices in manufacturing.

Occtoo

Seed Round in 2021
Occtoo AB is a software as a service company based in Vellinge, Sweden, that offers an Experience Data Platform aimed at enhancing digital experiences for retailers and brands. Founded in 2019, the platform enables marketers and content managers to easily orchestrate and personalize customer interactions by transforming enterprise data into actionable experience data. Occtoo provides no-code and low-code solutions that facilitate content personalization, dynamic product profiling, and customer insights, while also allowing for real-time data collection across various devices and channels. This technology streamlines the creation of applications and digital experiences, reducing the need for complex integrations. Notable clients include brands such as Cartier, Intersport, Fjällräven, and Filippa K, reflecting the platform's effectiveness in delivering tailored user experiences throughout the customer journey.

InRiver

Venture Round in 2020
InRiver AB is a software company that specializes in product information management (PIM) solutions, designed to assist businesses in effectively managing and distributing product information across various sales channels. Founded in 2007 and headquartered in Malmö, Sweden, with regional offices in Chicago, Amsterdam, and Stockholm, InRiver caters to both B2C and B2B multi-channel commerce professionals. The company's platform enables organizations to create, maintain, and uniformly present product information, including sales materials like videos and images, in multiple languages. With a client base of over 1,000 brands across 19 countries, InRiver aims to enhance revenue, customer satisfaction, and brand equity by transforming product information into strategic assets. The company has also established a strategic partnership with Aprimo LLC, further extending its capabilities in the market.

Open Payments

Seed Round in 2020
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.

Gesynta Pharma

Series C in 2020
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.

DbVis Software

Venture Round in 2020
DbVis Software AB, founded in 2003 and based in Stockholm, Sweden, specializes in developing database management and analysis software. Its flagship product, DbVisualizer, serves as a platform-independent tool that connects to various data sources, allowing users to manage database-specific objects and perform tasks such as creating, editing, and compiling procedures, functions, and triggers. The software also facilitates schema exports and the comparison of editors and result sets. DbVis Software emphasizes user feedback in its development process, ensuring that new features are added thoughtfully. The company offers dedicated support directly from its development team, maintaining a transparent and competitive pricing model that includes a free version of DbVisualizer, as well as discounts for educational and non-profit institutions. With over 6 million downloads and adoption by more than 28,000 companies across 145 countries, DbVis Software is committed to providing high-quality tools that enhance the efficiency of database users.

Nextory

Venture Round in 2020
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.

Barnebys

Venture Round in 2020
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

Elypta

Seed Round in 2020
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.

Freemelt

Seed Round in 2019
Freemelt AB, founded in 2017 and based in Mölndal, Sweden, specializes in the development and manufacture of metal 3D printers, with its flagship product being the Freemelt One. This printer utilizes an electron beam melting (EBM) platform and is designed for open-source, materials-innovation in additive manufacturing. Freemelt enables customers to create and test their own materials, providing a diverse range of options including oxygen-free high-conductivity copper, intermetallics, various steels, and nickel-based superalloys. The company focuses on serving research-scale material development, offering comprehensive support in production, marketing, sales, and servicing of its technology.

Ingrid Cloud

Venture Round in 2019
Ingrid Cloud AB, based in Stockholm, Sweden, specializes in a cloud-based computational application designed for wind simulation. Founded in 2014, the company offers an automated platform that streamlines the flow simulation and design optimization process. By converting computer-aided design (CAD) geometry into complex simulation models without requiring manual intervention, Ingrid Cloud's technology enhances accuracy, flexibility, and cost efficiency. This user-friendly service allows designers, architects, engineers, and researchers, even those without prior knowledge of computational fluid dynamics, to effectively predict flow and refine their designs.

Athera Biotechnologies

Venture Round in 2019
Athera Biotechnologies AB is a biopharmaceutical company based in Stockholm, Sweden, dedicated to developing targeted anti-inflammatory therapies and companion diagnostics for cardiovascular diseases (CVD). Founded in 2002, the company focuses on identifying immunological markers associated with atherosclerosis to enhance prevention and treatment strategies for CVD. Its product portfolio includes CVDefine, an immunological marker and ELISA kit designed for cardiovascular risk assessment, as well as innovative biopharmaceuticals like Annexin A5, which aims to prevent plaque rupture, and PC-mAb, a monoclonal antibody therapy targeting the uptake of oxidized LDL in macrophages. Athera's development efforts are grounded in research from the Karolinska Institutet and aim to meet the significant unmet medical needs in anti-inflammatory therapeutics for vascular diseases.

NuvoAir Medical

Venture Round in 2019
NuvoAir Medical, established in 2015 and headquartered in Stockholm, Sweden, specializes in a value-based specialty care platform for managing chronic heart and lung conditions. The company's core offering is a proactive, continuous virtual care model that combines personalized care, advanced monitoring technology, and analytics, delivered by a multidisciplinary team of healthcare professionals. NuvoAir collaborates with health plans and risk-bearing entities, employing flexible, value-based payment arrangements to reduce healthcare costs and improve patient outcomes.

Gesynta Pharma

Seed Round in 2019
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.

Apica

Series D in 2018
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

DPOrganizer

Series A in 2018
DPOrganizer, established in 2015 and based in Stockholm, Sweden, specializes in privacy management software. The company's platform enables businesses to map, visualize, report, and manage the processing of personal data, enhancing compliance, collaboration, and communication. It empowers professionals to control and protect customer and employee data, reducing risks and optimizing internal resources.

DPOrganizer

Series A in 2017
DPOrganizer, established in 2015 and based in Stockholm, Sweden, specializes in privacy management software. The company's platform enables businesses to map, visualize, report, and manage the processing of personal data, enhancing compliance, collaboration, and communication. It empowers professionals to control and protect customer and employee data, reducing risks and optimizing internal resources.

Barnebys

Venture Round in 2017
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

Adfenix

Series A in 2017
Adfenix AB is a Swedish company founded in 2014 and headquartered in Gothenburg. It specializes in developing a social media advertising platform tailored for real estate agents, enabling them to attract new customers through targeted advertising. The Adfenix platform leverages real estate data to empower agents, enhancing their ability to assist consumers in the home-buying journey. By providing quality advertising products and related services, Adfenix simplifies the marketing process for real estate professionals, allowing them to engage effectively with potential clients.

Starcounter

Venture Round in 2017
Starcounter, founded in 2006 by Joachim Wester, is a privately held company based in Stockholm, Sweden, with additional offices in Gdansk, Poland, and Palo Alto, USA. The company specializes in developing a database management platform aimed at revitalizing enterprise software systems. Its innovative platform integrates an in-memory database engine with an application server, facilitating the creation of high-performance business applications. Starcounter's research and development team, composed of over 30 experts in artificial intelligence, mathematics, and algorithms from seven different countries, drives the company's advancements in technology. By leveraging artificial intelligence and in-memory computing, Starcounter enhances the efficiency and performance of software applications for enterprises.

Fast Travel Games

Series A in 2017
Fast Travel Games, established in 2016 and headquartered in Stockholm, Sweden, specializes in developing virtual reality games. Founded by industry veterans from studios like EA DICE, Rovio, and Avalanche, the company aims to create immersive gaming experiences that allow players to explore rich narratives and interact with others in innovative ways. Their focus is on building games that leverage the unique capabilities of VR technology to provide deep, engaging universes for players.

Apica

Venture Round in 2017
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

Athera Biotechnologies

Venture Round in 2017
Athera Biotechnologies AB is a biopharmaceutical company based in Stockholm, Sweden, dedicated to developing targeted anti-inflammatory therapies and companion diagnostics for cardiovascular diseases (CVD). Founded in 2002, the company focuses on identifying immunological markers associated with atherosclerosis to enhance prevention and treatment strategies for CVD. Its product portfolio includes CVDefine, an immunological marker and ELISA kit designed for cardiovascular risk assessment, as well as innovative biopharmaceuticals like Annexin A5, which aims to prevent plaque rupture, and PC-mAb, a monoclonal antibody therapy targeting the uptake of oxidized LDL in macrophages. Athera's development efforts are grounded in research from the Karolinska Institutet and aim to meet the significant unmet medical needs in anti-inflammatory therapeutics for vascular diseases.

InRiver

Venture Round in 2017
InRiver AB is a software company that specializes in product information management (PIM) solutions, designed to assist businesses in effectively managing and distributing product information across various sales channels. Founded in 2007 and headquartered in Malmö, Sweden, with regional offices in Chicago, Amsterdam, and Stockholm, InRiver caters to both B2C and B2B multi-channel commerce professionals. The company's platform enables organizations to create, maintain, and uniformly present product information, including sales materials like videos and images, in multiple languages. With a client base of over 1,000 brands across 19 countries, InRiver aims to enhance revenue, customer satisfaction, and brand equity by transforming product information into strategic assets. The company has also established a strategic partnership with Aprimo LLC, further extending its capabilities in the market.

Sol Voltaics

Series D in 2017
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, that specializes in enhancing the efficiency of solar energy capture and generation. Established in 2007, the company develops and commercializes innovative nanomaterials, particularly through its flagship product, SolFilm. This solar panel additive, composed of gallium arsenide nanowires, is designed to improve the performance of conventional silicon solar modules. SolFilm is lightweight and transparent to infrared light, allowing it to convert high-energy sunlight directly into electricity while enabling additional power generation through underlying solar cells in a stacked configuration. By integrating these advanced technologies, Sol Voltaics aims to significantly boost the efficiency of photovoltaic modules, potentially increasing their output by up to 50%.

Nextory

Venture Round in 2017
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.

Barnebys

Venture Round in 2017
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

OxThera

Series D in 2016
OxThera AB is a biopharmaceutical company focused on developing treatments for primary and secondary hyperoxaluria, a condition that can lead to kidney stones and impaired kidney function. Founded in 2005 and based in Stockholm, Sweden, with an additional location in Knoxville, Tennessee, OxThera manufactures two main products: Oxabact and Oxazyme. Oxabact is an orally administered composition of live bacteria designed to enhance the removal of oxalate produced by the body, while Oxazyme is a non-systemic oral drug that contains recombinant oxalate decarboxylase, aimed at treating dietary hyperoxaluria and preventing kidney stones. The company holds worldwide patents for its innovative therapies and has received Orphan Drug designations for Oxabact in both Europe and the United States. Through its advanced biotherapy technologies, OxThera aims to improve kidney health and preserve organ function in patients affected by hyperoxaluria.

BONESUPPORT

Venture Round in 2016
BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Nextory

Venture Round in 2016
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.

Soundtrap

Series A in 2016
Soundtrap AB offers a cloud-based audio recording platform designed for collaboration in music and audio creation. Founded in 2012 and headquartered in Stockholm, Sweden, with an additional office in Silicon Valley, the platform supports a wide range of devices, including Mac, Windows, iPads, Android tablets and phones, Linux, and Chromebooks. Soundtrap has gained popularity, particularly in educational settings, where it is utilized for music instruction and podcast creation. The platform is recognized for its user-friendly interface and real-time collaboration features, which allow users to record and edit music or other audio content by connecting instruments or using built-in software options. Soundtrap is also a Google for Education Partner and has received accolades for its contribution to teaching and learning. In 2017, it became a subsidiary of Spotify AB.

Sol Voltaics

Series C in 2016
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, that specializes in enhancing the efficiency of solar energy capture and generation. Established in 2007, the company develops and commercializes innovative nanomaterials, particularly through its flagship product, SolFilm. This solar panel additive, composed of gallium arsenide nanowires, is designed to improve the performance of conventional silicon solar modules. SolFilm is lightweight and transparent to infrared light, allowing it to convert high-energy sunlight directly into electricity while enabling additional power generation through underlying solar cells in a stacked configuration. By integrating these advanced technologies, Sol Voltaics aims to significantly boost the efficiency of photovoltaic modules, potentially increasing their output by up to 50%.

Sol Voltaics

Grant in 2016
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, that specializes in enhancing the efficiency of solar energy capture and generation. Established in 2007, the company develops and commercializes innovative nanomaterials, particularly through its flagship product, SolFilm. This solar panel additive, composed of gallium arsenide nanowires, is designed to improve the performance of conventional silicon solar modules. SolFilm is lightweight and transparent to infrared light, allowing it to convert high-energy sunlight directly into electricity while enabling additional power generation through underlying solar cells in a stacked configuration. By integrating these advanced technologies, Sol Voltaics aims to significantly boost the efficiency of photovoltaic modules, potentially increasing their output by up to 50%.

Barnebys

Series A in 2015
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

Athera Biotechnologies

Venture Round in 2015
Athera Biotechnologies AB is a biopharmaceutical company based in Stockholm, Sweden, dedicated to developing targeted anti-inflammatory therapies and companion diagnostics for cardiovascular diseases (CVD). Founded in 2002, the company focuses on identifying immunological markers associated with atherosclerosis to enhance prevention and treatment strategies for CVD. Its product portfolio includes CVDefine, an immunological marker and ELISA kit designed for cardiovascular risk assessment, as well as innovative biopharmaceuticals like Annexin A5, which aims to prevent plaque rupture, and PC-mAb, a monoclonal antibody therapy targeting the uptake of oxidized LDL in macrophages. Athera's development efforts are grounded in research from the Karolinska Institutet and aim to meet the significant unmet medical needs in anti-inflammatory therapeutics for vascular diseases.

InRiver

Venture Round in 2015
InRiver AB is a software company that specializes in product information management (PIM) solutions, designed to assist businesses in effectively managing and distributing product information across various sales channels. Founded in 2007 and headquartered in Malmö, Sweden, with regional offices in Chicago, Amsterdam, and Stockholm, InRiver caters to both B2C and B2B multi-channel commerce professionals. The company's platform enables organizations to create, maintain, and uniformly present product information, including sales materials like videos and images, in multiple languages. With a client base of over 1,000 brands across 19 countries, InRiver aims to enhance revenue, customer satisfaction, and brand equity by transforming product information into strategic assets. The company has also established a strategic partnership with Aprimo LLC, further extending its capabilities in the market.

Barnebys

Venture Round in 2015
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

Starcounter

Seed Round in 2015
Starcounter, founded in 2006 by Joachim Wester, is a privately held company based in Stockholm, Sweden, with additional offices in Gdansk, Poland, and Palo Alto, USA. The company specializes in developing a database management platform aimed at revitalizing enterprise software systems. Its innovative platform integrates an in-memory database engine with an application server, facilitating the creation of high-performance business applications. Starcounter's research and development team, composed of over 30 experts in artificial intelligence, mathematics, and algorithms from seven different countries, drives the company's advancements in technology. By leveraging artificial intelligence and in-memory computing, Starcounter enhances the efficiency and performance of software applications for enterprises.

Glionova

Series A in 2014
Glionova AB is a development stage biopharmaceutical company based in Stockholm, Sweden, founded in 2014. The company focuses on developing therapies for challenging cancers, particularly glioblastoma, which is a common and aggressive primary brain tumor. Glionova is advancing its lead product, GLN-1001, an orally bioavailable small molecule designed to induce selective cell death in glioblastoma cells while sparing normal brain tissue. In addition to its research and development efforts, Glionova aims to market its product through strategic partnerships with global pharmaceutical companies that specialize in oncology.

Barnebys

Venture Round in 2014
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

BoMill

Venture Round in 2014
BoMill AB specializes in grain quality sorting solutions, focusing on the analysis and separation of granular products such as wheat, durum wheat, barley, and oats. The company offers two main products: TriQ, a large-scale grain quality sorting solution, and IQ, designed for laboratory use. Founded in 2001 by Swedish biochemist Bo Löfqvist, BoMill has extensive expertise in single kernel sorting technology. The company provides additional support services, including customer care and installation, and serves various sectors such as seed cleaning, malt houses, and flour mills. Headquartered in Malmö, Sweden, BoMill markets its technology and know-how across Europe, North America, and Australia, utilizing its own sales organization as well as agents and distributors.

InDex Pharmaceuticals

Venture Round in 2014
InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).

MagComp

Venture Round in 2013
MagComp AB, established in 2005 as a spin-off from Lund University, is based in Eslöv, Sweden, and specializes in the development, manufacturing, and supply of inductors and industrial induction heating systems. The company provides solutions for a variety of applications, including pre-heating, re-heating of strip metal and wire, drying, cleaning, thermal compensation, and curing processes. MagComp also produces innovative products such as MagChoke, along with LC, LCL, and sinus filters, which are utilized in systems like uninterruptible power supplies, solar inverters, and active harmonic filters. The company emphasizes energy efficiency and operates in close collaboration with Lund University to enhance its research and development efforts. With a focus on providing efficient magnetic materials and microprocessors, MagComp aims to help clients reduce operating costs and improve productivity, thereby increasing their competitiveness in the manufacturing sector.

Calliditas Therapeutics

Series C in 2013
Calliditas Therapeutics AB, headquartered in Stockholm, Sweden, is a specialty pharmaceutical company dedicated to developing high-quality medicines for patients with significant unmet medical needs in niche indications. The company focuses on the development and commercialization of Nefecon (also known as TARPEYO), a unique formulation designed to treat IgA nephropathy (IgAN), an inflammatory renal disease. This patented, locally acting formulation combines a time lag effect with a concentrated release of budesonide within a designated target area. Calliditas is conducting a global Phase 3 study for Nefecon and aims to commercialize it in the United States.

Sol Voltaics

Series B in 2013
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, that specializes in enhancing the efficiency of solar energy capture and generation. Established in 2007, the company develops and commercializes innovative nanomaterials, particularly through its flagship product, SolFilm. This solar panel additive, composed of gallium arsenide nanowires, is designed to improve the performance of conventional silicon solar modules. SolFilm is lightweight and transparent to infrared light, allowing it to convert high-energy sunlight directly into electricity while enabling additional power generation through underlying solar cells in a stacked configuration. By integrating these advanced technologies, Sol Voltaics aims to significantly boost the efficiency of photovoltaic modules, potentially increasing their output by up to 50%.

InRiver

Venture Round in 2013
InRiver AB is a software company that specializes in product information management (PIM) solutions, designed to assist businesses in effectively managing and distributing product information across various sales channels. Founded in 2007 and headquartered in Malmö, Sweden, with regional offices in Chicago, Amsterdam, and Stockholm, InRiver caters to both B2C and B2B multi-channel commerce professionals. The company's platform enables organizations to create, maintain, and uniformly present product information, including sales materials like videos and images, in multiple languages. With a client base of over 1,000 brands across 19 countries, InRiver aims to enhance revenue, customer satisfaction, and brand equity by transforming product information into strategic assets. The company has also established a strategic partnership with Aprimo LLC, further extending its capabilities in the market.

Foap

Seed Round in 2013
Foap AB, established in 2011 and headquartered in Kristianstad, Sweden, operates a unique online marketplace that facilitates the buying and selling of photos. Users can upload their photos via the Foap mobile application, with each image potentially being sold an unlimited number of times. The company shares revenue with photographers on a 50/50 basis, currently pricing each licensed photo at $10. Foap's mission is to build a diverse image database, focusing on natural and local content to cater to brands seeking authentic visuals for marketing purposes.

Mantex

Venture Round in 2013
Mantex AB manufactures and sells industrial X-ray scanners, primarily serving the bioenergy, pulp and paper, and research sectors both in Sweden and internationally. Established in 1987 and based in Kista, Sweden, the company specializes in biofuel analyzers that evaluate the quality of wood-based biofuels, as well as flow scanners designed to assess wood chips for pulp and paper production. Mantex's innovative technology enables real-time analysis of organic materials used in various industrial processes, helping to identify foreign objects and measure material properties effectively. This capability is particularly important in addressing the challenges posed by variations in the water content of raw materials, which can impact the purchasing and processing of organic matter in large quantities.

Flexenclosure

Series A in 2013
Flexenclosure AB is an engineering firm based in Stockholm, Sweden, specializing in the design and manufacture of prefabricated modular data centers and intelligent power management solutions. The company's primary products include eCentre, a customizable data center that can be tailored for various operational needs, and eSite, a modular diesel-battery hybrid power system ideal for remote and unreliable power scenarios. Flexenclosure focuses on providing reliable, factory-built solutions that enhance flexibility for telecom operators worldwide, enabling them to expand and modernize their networks efficiently. The firm emphasizes the use of renewable energy, illustrating how such solutions can reduce operating costs while contributing to social development, particularly in underserved rural areas through initiatives like Community Power. Established in 1989, Flexenclosure operates globally with offices in multiple countries, serving notable clients in the telecommunications sector.

Qwaya

Series A in 2013
Qwaya AB is a technology company based in Stockholm, Sweden, that specializes in providing a comprehensive advertising tool for Facebook marketing. The platform enables business clients to create, publish, track, optimize, and organize their Facebook advertisement campaigns with ease. Qwaya's tool is designed for a wide range of advertisers and agencies, featuring user-friendly functionality and a low flat fee pricing model. In addition to its core capabilities, Qwaya offers options for scheduling campaigns, setting performance-based rules to pause ads, and facilitating collaboration among team members. As a certified Facebook Preferred Marketing Developer, Qwaya is committed to enhancing social media marketing through its advanced tools and resources, including training webinars to support users in improving their advertising strategies.

ClearCar

Venture Round in 2012
ClearCar AB is a privately held company based in Grums, Sweden, specializing in vehicle inspection services. It operates vehicle inspection and repair stations, offering a range of automotive services that include inspection, repair, and car-washing. As of April 2016, ClearCar functions as a subsidiary of Besikta Bilprovning i Sverige AB.

Avtal24

Venture Round in 2012
AB Avtal24 is a Swedish company that specializes in providing online legal services, founded in 2004 and headquartered in Stockholm. The company offers a range of agreements for both individuals and businesses, including wills, gift deeds, and stockholder agreements. Avtal24 aims to make legal services accessible and affordable, allowing customers to create agreements online or consult with a lawyer by phone at a fixed price. By leveraging innovative technology and a strong emphasis on customer benefit, Avtal24 seeks to ensure that everyone has access to legal security and expertise.

agreement24 avtal24

Venture Round in 2012
Agreement24 is a legal services company that uses document automation technology, web applications and legal content to deliver legal services to consumers and businesses across Europe. The first version of the virtual lawyer was launched on the Swedish market early 2007 (avtal24). Agreement24:s cloud based platform, built on unique software, is easy and efficient to scale into new markets and products. Regardless of the jurisdiction (or the law) it can create the question flows, user design, database and the agreements efficiently. The more complex legal market the bigger the opportunity with this new technology that completely transforms and enhance the customer experience of legal help.

Anyfi Networks

Seed Round in 2012
Anyfi Networks AB, based in Malmö, Sweden, specializes in mobile Wi-Fi solutions. It leverages existing Wi-Fi infrastructure and user credentials for secure, seamless connectivity. The company's key products include Anyfi.net, enabling multiple Wi-Fi networks to be accessible and automatically connect devices, and Anyfi.net Mobile, which offloads mobile data onto fixed-line networks using SIM card authentication. Founded in 2009, Anyfi Networks aims to unlock the potential of private Wi-Fi networks for efficient and secure mobile data traffic management.

Apica

Series C in 2012
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

BONESUPPORT

Venture Round in 2012
BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Nuevolution

Venture Round in 2012
Nuevolution is a small molecule lead discovery company founded in 2001 and based in Copenhagen, Denmark. The company has developed Chemetics®, a patented hybrid technology that combines wet chemistry and molecular biology to accelerate drug discovery. This platform facilitates the rapid synthesis and DNA-tagging of over 1 billion diverse small molecule compounds, allowing for efficient screening and identification of potent drug leads. Nuevolution partners with pharmaceutical and biotechnology companies, having established agreements with major firms such as Merck, GlaxoSmithKline, and Novartis. The company is also involved in a joint venture with EpiTherapeutics and ExpreS2ion Biotechnologies to develop small molecule drugs targeting epigenetic factors, supported by a project budget from the Danish High Technology Fund. Nuevolution focuses on developing treatments for oncology and inflammatory diseases and also provides contract research services, generating revenue from multiple countries, including Denmark, Sweden, and the USA. The company is privately owned by several key Scandinavian investors.

Barnebys

Venture Round in 2012
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

Clavister Holding

Venture Round in 2012
Clavister Holding AB is a prominent cybersecurity vendor based in Sweden, with over 20 years of experience in the industry. The company develops, produces, and sells a comprehensive range of network security solutions designed to protect digital assets and ensure business continuity for clients worldwide, including communication service providers, governments, enterprises, and managed security service providers. Clavister's product portfolio encompasses identity and access management solutions, endpoint security, and both physical and virtualized network security products tailored for cloud environments. Its clientele spans over 150 countries, with a significant portion of revenue generated from operations within Sweden and across Europe, Asia, and other global markets.

Footway

Venture Round in 2012
Footway is an online shoe retailer headquartered in Kista, Sweden. The company operates a platform with specialized online stores, offering a diverse selection of approximately 800 brands, including well-known names such as Nike, Adidas, Converse, and Dr. Martens. Footway serves around 2 million customers across approximately 24 markets, providing a wide range of footwear options tailored to various preferences and needs.

Calliditas Therapeutics

Venture Round in 2012
Calliditas Therapeutics AB, headquartered in Stockholm, Sweden, is a specialty pharmaceutical company dedicated to developing high-quality medicines for patients with significant unmet medical needs in niche indications. The company focuses on the development and commercialization of Nefecon (also known as TARPEYO), a unique formulation designed to treat IgA nephropathy (IgAN), an inflammatory renal disease. This patented, locally acting formulation combines a time lag effect with a concentrated release of budesonide within a designated target area. Calliditas is conducting a global Phase 3 study for Nefecon and aims to commercialize it in the United States.

Zaplox

Venture Round in 2011
Zaplox AB specializes in mobile key solutions tailored for the hospitality industry, offering a suite of digital guest services designed to enhance the overall guest experience. Founded in 2010 and headquartered in Lund, Sweden, the company provides various products, including the Zaplox Traveler app for mobile check-in and checkout, the Zaplox SDK for integrating mobile and keyless capabilities, and the Zaplox Premium app, which allows for custom branding and mobile key functionalities. Additionally, Zaplox offers a self-service kiosk option for hotel lobbies. Its solutions cater to hotels, resorts, and casinos across EMEA, North America, and APAC, enabling seamless digital interactions from reservation to departure. By focusing on enhancing the guest journey with features such as pre-stay messaging and promotional offers, Zaplox has positioned itself as an innovator in the hospitality sector.

SEEC AB

Venture Round in 2011
SEEC AB, established in October 2006, specializes in the development, marketing, and sale or leasing of energy stores equipped with energy modules designed for large buildings. The company focuses primarily on the domestic Swedish market while also pursuing opportunities for export. Through its innovative products, SEEC aims to enhance energy efficiency and sustainability in building management.

Apica

Series B in 2011
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

Sol Voltaics

Venture Round in 2011
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, that specializes in enhancing the efficiency of solar energy capture and generation. Established in 2007, the company develops and commercializes innovative nanomaterials, particularly through its flagship product, SolFilm. This solar panel additive, composed of gallium arsenide nanowires, is designed to improve the performance of conventional silicon solar modules. SolFilm is lightweight and transparent to infrared light, allowing it to convert high-energy sunlight directly into electricity while enabling additional power generation through underlying solar cells in a stacked configuration. By integrating these advanced technologies, Sol Voltaics aims to significantly boost the efficiency of photovoltaic modules, potentially increasing their output by up to 50%.

Apica

Venture Round in 2011
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

BONESUPPORT

Venture Round in 2011
BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Keybroker

Venture Round in 2011
Keybroker AB, established in 2005 and headquartered in Stockholm, Sweden, specializes in online marketing solutions for European advertisers. The company offers comprehensive services, including campaign management and advertising technology, to help businesses profitably drive online sales across various digital channels such as Google and Facebook. Keybroker's client base spans diverse sectors like travel, finance, electronics, retail, and entertainment.

InDex Pharmaceuticals

Private Equity Round in 2011
InDex Pharmaceuticals AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, focused on developing treatments for ulcerative colitis and other immunological diseases. The company’s lead product, cobitolimod, offers a local anti-inflammatory effect that aids in mucosal healing and alleviates clinical symptoms. Additionally, InDex Pharmaceuticals utilizes its proprietary DNA-based ImmunoModulatory Sequences (DIMS) platform to create drugs aimed at various therapeutic areas, including inflammation and cancer. The company also provides DiBiCol, a diagnostic kit designed to monitor specific biomarkers related to ulcerative colitis and Crohn’s disease from a single colonic biopsy. Founded in 2016, InDex Pharmaceuticals operates as a subsidiary of InDex Pharmaceuticals Holding AB (publ).

RxEye

Venture Round in 2010
RxEye is a Swedish company that specializes in providing solutions for radiology departments within both public and private healthcare sectors. It operates as a subsidiary of Sectra Aktiebolag and focuses on creating an exchange platform for medical image reading services, allowing radiology managers and specialists to share expertise, images, and patient information securely. The company's web-based system facilitates remote reviewing of medical imaging, supporting procurement, appointment management, and access to radiology and pathology images. By prioritizing ease of use and adherence to legal requirements, RxEye enhances collaboration and resource sharing among healthcare professionals.

Cardoz

Series A in 2010
Cardoz AB manufactures anti-inflammatory pharmaceuticals to combat heart and vascular disorders. The company was founded in 2006 and is based in Stockholm, Sweden.

Nanoradio

Venture Round in 2010
Nanoradio AB, established in 2004 and headquartered in Kista, Sweden, was a fabless semiconductor company specializing in wireless solutions for the cellular handset and consumer electronics markets. It offered a range of products, including multimedia solutions, single chip system in package, wireless LAN products, mobile phone products, and chipsets, along with accompanying software such as diagnostic tools and software development kits. Nanoradio's products were used in various devices like wireless phones, headsets, portable audio devices, handheld computing devices, and mobile gaming platforms. The company operated sales offices in Korea, Japan, and the United States, and functioned as a subsidiary of Wireless Experience AB.

Coresonic

Venture Round in 2010
Coresonic AB specializes in the development of digital signal processor (DSP) technology tailored for the wireless industry, focusing on baseband applications. Founded in 2004, the company emerged from a three-year research initiative at Linköping University in Sweden, recognized for its expertise in computer science. The founders, including notable professors and researchers, aimed to address the market's demand for a DSP architecture that is efficient, fully programmable, and scalable, while avoiding the complexity and high power consumption associated with traditional VLIW DSPs. Coresonic offers a unique single instruction-flow multiple tasks (SIMT) DSP and provides a comprehensive developer studio that includes tools for coding, debugging, and profiling firmware in C++ or assembler, thereby supporting developers throughout the entire development process. The company was further strengthened in 2009 with the addition of Johan Lodenius, who brought extensive experience in management and international marketing within the wireless and semiconductor sectors.

Nanoradio

Venture Round in 2009
Nanoradio AB, established in 2004 and headquartered in Kista, Sweden, was a fabless semiconductor company specializing in wireless solutions for the cellular handset and consumer electronics markets. It offered a range of products, including multimedia solutions, single chip system in package, wireless LAN products, mobile phone products, and chipsets, along with accompanying software such as diagnostic tools and software development kits. Nanoradio's products were used in various devices like wireless phones, headsets, portable audio devices, handheld computing devices, and mobile gaming platforms. The company operated sales offices in Korea, Japan, and the United States, and functioned as a subsidiary of Wireless Experience AB.

Conveneer

Series A in 2009
Mashmobile Sweden AB, also known as Mikz, operates as an information technology company which offers software products for direct content dissemination between mobile phones, personal digital assistants, laptops, and personal computers. The company operates in the fields of fixed-mobile convergence and mobile communities based on a P2P technology. Its technology enables users to navigate between devices by surfing from a personal computer to a mobile phone using a Web browser, or streaming music from a personal digital assistant to a mobile phone. It was formerly known as Conveneer AB. Mashmobile Sweden AB was founded in 2004 and is based in Lund, Sweden.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.